SCHEMBL21687463

SCHEMBL21687463

N#Cc1cccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2-c2cccc(-n3c4ccc(C#N)cc4c4cc(C#N)ccc43)c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.34
TDP2 O95551 3/20 0.34
ALDH1A1 P00352 4/20 0.33
CLK4 Q9HAZ1 3/20 0.33
GRM5 P41594 1/20 0.33
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 3/20 0.33
CYP2D6 P10635 3/20 0.33
TSHR P16473 3/20 0.33
CYP2C19 P33261 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C9 P11712 1/20 0.33
G6PD P11413 1/20 0.33
TP53 P04637 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688203 0.97 CYP1A2 (0.33) ADRA2CTDP2ALDH1A1CLK4GRM5
SCHEMBL21687702 0.97 TDP2 (0.35) ADRA2CTDP2ALDH1A1CLK4GRM5
SCHEMBL21687839 0.95 TDP2 (0.34) ADRA2CTDP2ALDH1A1CLK4GRM5
SCHEMBL21687989 0.94 KDM4E (0.35) ADRA2CTDP2ALDH1A1CLK4CYP1A2
SCHEMBL21687630 0.93 KDM4E (0.36) ADRA2CALDH1A1CLK4GRM5CYP1A2
SCHEMBL21687709 0.92 CNR2 (0.35) TDP2ALDH1A1CLK4CYP1A2CYP3A4
SCHEMBL21687835 0.90 RARG (0.33) TDP2ALDH1A1CLK4CYP1A2CYP3A4
SCHEMBL21688004 0.90 TDP2 (0.35) TDP2ALDH1A1CLK4GRM5CYP1A2
SCHEMBL21687707 0.90 TDP2 (0.35) TDP2ALDH1A1CLK4GRM5TSHR
SCHEMBL21687469 0.90 GABRA1 (0.36) TDP2ALDH1A1LMNAMAPK1G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ADRA2C 3329/4885TDP2 4123/4885ALDH1A1 616/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ADRA2C 3329/4885TDP2 4123/4885ALDH1A1 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.